KL
CRL icon

KWMG LLC’s Charles River Laboratories CRL Stock Holding History

KWMG LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-170
Closed -$25K – 180
2019
Q1 		$25K Sell
170
-259
-60% -$34K 0.01% 209
2018
Q4 		$49K Buy
429
+105
+32% +$13.1K 0.01% 171
2018
Q3 		$44K Buy
+324
New +$40K 0.01% 172

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

KWMG LLC's CRL Position: Q2 2019 in Review

KWMG LLC sold out of Charles River Laboratories (CRL) in Q2 2019, closing a stake of 170 shares — an estimated $25K sold.

KWMG LLC first reported a position in CRL in Q3 2018 and held it in 3 quarters. The position peaked at $49K in Q4 2018. 405 funds tracked by Wall St. Rank hold CRL as of Q2 2019.

  • KWMG LLC reported no remaining Charles River Laboratories position as of Q2 2019 after selling out during the quarter.
  • KWMG LLC sold 170 Charles River Laboratories shares in Q2 2019, an estimated $25K.
  • KWMG LLC first reported a position in Charles River Laboratories in Q3 2018 and held it in 3 quarters.
  • KWMG LLC's Charles River Laboratories position peaked at $49K in Q4 2018.
  • 405 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2019.

Based on KWMG LLC's 13F filing for Q2 2019, filed 10 Jul 2019.